| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
BLYSBAFFSystemic lupus erythematosusAPRILTransplantationRituximabBelimumab| 1 | 2008 | B lymphocyte stimulator: a new target for treating B cell malignancies. | 
| + | - | nl | Chin Med J (Engl) 121(14):1319-23 (2008) Sun J |
| 2 | 2006 | Space, selection, and surveillance: setting boundaries with BLyS. |
| + | - | nl | J Immunol 176(11):6405-10 (2006) Miller JP |
| 3 | 2006 | The BLyS/BAFF family of ligands and receptors: key targets in the therapy and understanding of autoimmunity. |
| + | - | nl | Ann Rheum Dis 65 Suppl 3():iii34-6 (2006) Cancro MP |
| 4 | 2004 | The current status of targeting BAFF/BLyS for autoimmune diseases. |
| + | - | nl | Arthritis Res Ther 6(5):197-202 (2004) Ramanujam M |
| 5 | 2003 | SLE--systemic lupus erythematosus: a BLySful, yet BAFFling, disorder. |
| + | - | nl | Arthritis Res Ther 5(3):136-8 (2003) Stohl W |
| 6 | 2009 | The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus. |
| + | - | nl | J Clin Invest 119(5):1066-73 (2009) Cancro MP |
| 7 | 2010 | Systemic lupus erythematosus and its ABCs (APRIL/BLyS complexes). |
| + | - | nl | Arthritis Res Ther 12(2):111 (2010) Stohl W |
| 8 | 2010 | B-lymphocyte homeostasis and BLyS-directed immunotherapy in transplantation. |
| + | - | nl | Transplant Rev (Orlando) 24(4):207-21 (2010) |
| 9 | 2010 | Targeting B cells for the treatment of SLE: the beginning of the end or the end of the beginning? |
| + | - | nl | Discov Med 10(54):416-24 (2010) |
